Search research articles
Contact Us
Filters
Showing results (21-30 of 37) with videos related to
Page
of 4
Sort By:
Expert Review of Pharmacoeconomics & Outcomes Research
|
January 16, 2016
Saving orphan drug legislations: misconceptions and clarifications
Hanna I Hyry, Timothy M Cox, Jonathan C P Roos
The Journal of Rheumatology
|
January 12, 2007
Interstitial pneumonitis and anti-tumor necrosis factor-alpha therapy
Jonathan C P Roos, Edwin R Chilvers, Andrew J K Ostor
Orphanet Journal of Rare Diseases
|
August 22, 2015
Compassionate use of orphan drugs
Hanna I Hyry, Jeremy Manuel, Timothy M Cox, et al.
Orphanet Journal of Rare Diseases
|
September 10, 2013
The legal imperative for treating rare disorders
Hanna I Hyry, Jonathan C P Roos, Jeremy Manuel, et al.
The British Journal of Ophthalmology
|
January 7, 2019
Ophthalmic manifestations of Gaucher disease: the most common lysosomal storage disorder
Aaron W Winter, Ali Salimi, Luis H Ospina, et al.
Ophthalmic Plastic and Reconstructive Surgery
|
September 11, 2018
Reply Re: "Can We Improve the Tolerance of an Ocular Prosthesis by Enhancing Its Surface Finish?"
Andre S Litwin, Emma Worrell, Jonathan C P Roos, et al.
Ophthalmology
|
April 5, 2011
Latency vs saccadic parameters in lysosomal trials
Jonathan C P Roos, Robin H Lachmann, Roger H Carpenter, et al.
Ophthalmic Plastic and Reconstructive Surgery
|
March 9, 2017
Can We Improve the Tolerance of an Ocular Prosthesis by Enhancing Its Surface Finish?
Andre S Litwin, Emma Worrell, Jonathan C P Roos, et al.
Eye (London, England)
|
December 13, 2018
T2-relaxation mapping and fat fraction assessment to objectively quantify clinical activity in thyroid eye disease: an initial feasibility study
Tilak Das, Jonathan C P Roos, Andrew J Patterson, et al.
Plastic and Reconstructive Surgery. Global Open
|
August 25, 2015
Eyelid and Sternum Fibroblasts Differ in Their Contraction Potential and Responses to Inflammatory Cytokines
He Li, Jonathan C P Roos, Geoffrey E Rose, et al.
Page
of 4
Search research articles
Search
Showing results (21-30 of 37) with videos related to
Sort By:
Page
of 4
Expert Review of Pharmacoeconomics & Outcomes Research
|
January 16, 2016
Saving orphan drug legislations: misconceptions and clarifications
Hanna I Hyry, Timothy M Cox, Jonathan C P Roos
The Journal of Rheumatology
|
January 12, 2007
Interstitial pneumonitis and anti-tumor necrosis factor-alpha therapy
Jonathan C P Roos, Edwin R Chilvers, Andrew J K Ostor
Orphanet Journal of Rare Diseases
|
August 22, 2015
Compassionate use of orphan drugs
Hanna I Hyry, Jeremy Manuel, Timothy M Cox, et al.
Orphanet Journal of Rare Diseases
|
September 10, 2013
The legal imperative for treating rare disorders
Hanna I Hyry, Jonathan C P Roos, Jeremy Manuel, et al.
The British Journal of Ophthalmology
|
January 7, 2019
Ophthalmic manifestations of Gaucher disease: the most common lysosomal storage disorder
Aaron W Winter, Ali Salimi, Luis H Ospina, et al.
Ophthalmic Plastic and Reconstructive Surgery
|
September 11, 2018
Reply Re: "Can We Improve the Tolerance of an Ocular Prosthesis by Enhancing Its Surface Finish?"
Andre S Litwin, Emma Worrell, Jonathan C P Roos, et al.
Ophthalmology
|
April 5, 2011
Latency vs saccadic parameters in lysosomal trials
Jonathan C P Roos, Robin H Lachmann, Roger H Carpenter, et al.
Ophthalmic Plastic and Reconstructive Surgery
|
March 9, 2017
Can We Improve the Tolerance of an Ocular Prosthesis by Enhancing Its Surface Finish?
Andre S Litwin, Emma Worrell, Jonathan C P Roos, et al.
Eye (London, England)
|
December 13, 2018
T2-relaxation mapping and fat fraction assessment to objectively quantify clinical activity in thyroid eye disease: an initial feasibility study
Tilak Das, Jonathan C P Roos, Andrew J Patterson, et al.
Plastic and Reconstructive Surgery. Global Open
|
August 25, 2015
Eyelid and Sternum Fibroblasts Differ in Their Contraction Potential and Responses to Inflammatory Cytokines
He Li, Jonathan C P Roos, Geoffrey E Rose, et al.
Page
of 4